Titelia

Fund shareholders of Cinclus Pharma Holding AB

ISIN SE0020388577 · Sweden

Fund shareholders
9
Of which ETFs
0 9 other funds
Value held
≈ 1.3M $ 12M SEK
FundSharesValueWeight in fund
Handelsbanken Sverige Index Criteria Handelsbanken Fonder AB 270,2404.6M SEK0.01 %as of Mar 31, 2026 ↗
Storebrand Sverige Plus Storebrand Asset Management AS 169,3322.9M SEK0.01 %as of Mar 31, 2026 ↗
PLUS Mikrobolag Sverige Index ISEC Services AB 123,7782.1M SEK0.55 %as of Mar 31, 2026 ↗
Storebrand Sverige Småbolag Plus Storebrand Asset Management AS 57,213965.8K SEK0.03 %as of Mar 31, 2026 ↗
SEB Sverige Indexnära SEB Funds AB 34,539583K SEK0.00 %as of Mar 31, 2026 ↗
SEB Sverige Indexfond SEB Funds AB 24,965421.4K SEK0.00 %as of Mar 31, 2026 ↗
Skandia Sverige Exponering Skandia Fonder AB 16,873284.8K SEK0.00 %as of Mar 31, 2026 ↗
PLUS Hälsovård Sverige Index ISEC Services AB 8,623145.6K SEK0.25 %as of Mar 31, 2026 ↗
Småbolag Sverige Exponering Skandia Fonder AB 2,91449.2K SEK0.02 %as of Mar 31, 2026 ↗

Download this table: CSV, JSON

Report an error

The funds most exposed to it

The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.

FundWeight in fund
PLUS Mikrobolag Sverige Index ISEC Services AB 0.55 %as of Mar 31, 2026 ↗
PLUS Hälsovård Sverige Index ISEC Services AB 0.25 %as of Mar 31, 2026 ↗
Storebrand Sverige Småbolag Plus Storebrand Asset Management AS 0.03 %as of Mar 31, 2026 ↗
Småbolag Sverige Exponering Skandia Fonder AB 0.02 %as of Mar 31, 2026 ↗
Storebrand Sverige Plus Storebrand Asset Management AS 0.01 %as of Mar 31, 2026 ↗
Handelsbanken Sverige Index Criteria Handelsbanken Fonder AB 0.01 %as of Mar 31, 2026 ↗
SEB Sverige Indexfond SEB Funds AB 0.00 %as of Mar 31, 2026 ↗
Skandia Sverige Exponering Skandia Fonder AB 0.00 %as of Mar 31, 2026 ↗
SEB Sverige Indexnära SEB Funds AB 0.00 %as of Mar 31, 2026 ↗
Cite this page

Titelia. "Fund shareholders of Cinclus Pharma Holding AB". https://titelia.com/en/stocks/cinclus-pharma-holding-ab-SE0020388577